222
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

A Polydrug and Psychosocial Profile of Synthetic Cannabinoid Use in a New York City Community Sample, 2016–2017

, , &

References

  • Barnett, B. S., & Owusu, M. (2016). Synthetic cannabinoid use in a transitional housing shelter: A survey to characterize awareness of risks and reasons for use. American Journal of Psychiatry Residents’ Journal, 11(10), 4–6. doi:10.1176/appi.ajp-rj.2016.111003
  • Cooper, Z. D. (2016). Adverse effects of synthetic cannabinoids: Management of acute toxicity and withdrawal. Current Psychiatry Reports, 18(5), 52. doi:10.1007/s11920-016-0694-1
  • Dowell, D., Arias, E., Kochanek, K., Anderson, R., Guy, G. P., Losby, J. L., & Baldwin, G. (2017). Contribution of opioid-involved poisoning to the change in life expectancy in the United States, 2000–2015. JAMA, 318(11), 1065. doi:10.1001/jama.2017.9308
  • Joseph, A. M., Manseau, M. W., Lalane, M., Rajparia, A., & Lewis, C. F. (2017). Characteristics associated with synthetic cannabinoid use among patients treated in a public psychiatric emergency setting. The American Journal of Drug and Alcohol Abuse, 43(1), 117–122. doi:10.1080/00952990.2016.1240799
  • Kelly, B. C., Wells, B. E., Pawson, M., Leclair, A., Parsons, J. T., & Golub, S. A. (2013). Novel psychoactive drug use among younger adults involved in US nightlife scenes. Drug and Alcohol Review, 32(6), 588–593. doi:10.1111/dar.12058
  • Kunins, H. (2015). Increase in synthetic cannabinoid (K2)-related adverse events and emergency department visits, New York City. New York, NY: Department of Health and Mental Hygiene
  • Manseau, M. W., Rajparia, A., Joseph, A., Azarchi, S., Goff, D., Satodiya, R., & Lewis, C. F. (2017). Clinical characteristics of synthetic cannabinoid use in a large urban psychiatric emergency setting. Substance Use & Misuse, 52(6), 822–825. doi:10.1080/10826084.2016.1263663
  • Monte, A. A., Calello, D. P., Gerona, R. R., Hamad, E., Campleman, S. L., Brent, J., … On behalf of the ACMT Toxicology Investigators Consortium (ToxIC). (2017). Characteristics and treatment of patients with clinical illness due to synthetic cannabinoid inhalation reported by medical toxicologists: A ToxIC database study. Journal of Medical Toxicology, 13(2), 146–152. doi:10.1007/s13181-017-0605-9
  • Müller, H., Huttner, H., Köhrmann, M., Wielopolski, J., Kornhuber, J., & Sperling, W. (2010). Panic attack after spice abuse in a patient with ADHD. Pharmacopsychiatry, 43(4), 152–153. doi:10.1055/s-0029-1243252
  • Neill, K. A. (2017, March). Fake weed, real consequences: Effective strategies for addressing synthetic cannabinoids in Houston. Retrieve from http://www.bakerinstitute.org/research/synthetic-marijuana/.
  • Palamar, J. J., Su, M. K., & Hoffman, R. S. (2016). Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011–2014. The American Journal of Drug and Alcohol Abuse, 42(1), 39–47. doi:10.3109/00952990.2015.1106551
  • Papanti, D., Schifano, F., Botteon, G., Bertossi, F., Mannix, J., Vidoni, D., … Bonavigo, T. (2013). “Spiceophrenia”: A systematic overview of “Spice”-related psychopathological issues and a case report. Human Psychopharmacology: Clinical and Experimental, 28(4), 379–389. doi:10.1002/hup.2312
  • Springer, Y. P., Gerona, R., Scheunemann, E., Shafer, S. L., Lin, T., Banister, S. D., … McLaughlin, J. B. (2016). Increase in adverse reactions associated with use of synthetic cannabinoids — Anchorage, Alaska, 2015–2016. MMWR. Morbidity and Mortality Weekly Report, 65(40), 1108–1111. doi:10.15585/mmwr.mm6540a4
  • Trecki, J., Gerona, R. R., & Schwartz, M. D. (2015). Synthetic cannabinoid-related illnesses and deaths. New England Journal of Medicine, 373(2), 103–107.
  • Van der Veer, N., & Friday, J. (2011). Persistent psychosis following the use of spice. Schizophrenia Research, 130(1–3), 285–286. doi:10.1016/j.schres.2011.04.022
  • Vandrey, R., Dunn, K. E., Fry, J. A., & Girling, E. R. (2012). A survey study to characterize use of spice products (synthetic cannabinoids). Drug and Alcohol Dependence, 120(1–3), 238–241. doi:10.1016/j.drugalcdep.2011.07.011
  • Wagner, K. D., Armenta, R. F., Roth, A. M., Maxwell, J. C., Cuevas-Mota, J., & Garfein, R. S. (2014). Use of synthetic cathinones and cannabimimetics among injection drug users in San Diego, California. Drug and Alcohol Dependence, 141, 99–106. doi:10.1016/j.drugalcdep.2014.05.007
  • Zawilska, J. B., & Wojcieszak, J. (2014). Spice/K2 drugs – More than innocent substitutes for marijuana. The International Journal of Neuropsychopharmacology, 17(3), 509–525. doi:10.1017/S1461145713001247

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.